Trial intelligence / Profile preview

Ketorolac 10, 20, and 30mg for Renal Colic Pain

NCT03665753Phase 1Completed

Sponsor
Tehran University of Medical Sciences
Start
Nov 2018
Primary completion
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, triple-blind trial of ketorolac in Renal colic (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Visual Analogue Scale. Started Nov 2018; status: completed.

02

Drugs

ketorolac
03

Conditions

Renal colic

Beyond the preview

Go deeper on NCT03665753.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03665753.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call